REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Schnell Bio Pharmaceuticals Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Schnell Bio Pharmaceuticals Inc. Profile Updated: April 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Schnell Bio Pharmaceuticals Inc. is an enterprise in South Korea, with the main office in Seoul. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on December 03, 1960. The total number of employees is currently 445 (2025). In 2025, the company reported a net sales revenue increase of 8.68%. Its’ total assets recorded a negative growth of 0.68%. The net profit margin of Schnell Bio Pharmaceuticals Inc. decreased by 74.02% in 2025.

Headquarters
6301 Ogeum-Ro 19 Gil, Songpa-Gu
Seoul; Seoul; Postal Code: 138-050

Contact Details: Purchase the Schnell Bio Pharmaceuticals Inc. report to view the information.

Website: http://www.schnell.kr

Basic Information
Total Employees:
Purchase the Schnell Bio Pharmaceuticals Inc. report to view the information.
Outstanding Shares:
Purchase the Schnell Bio Pharmaceuticals Inc. report to view the information.
Registered Capital:
Purchase the Schnell Bio Pharmaceuticals Inc. report to view the information.
Financial Auditors:
Purchase the Schnell Bio Pharmaceuticals Inc. report to view the information.
Incorporation Date:
December 03, 1960
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
5.46%
Purchase this report to view the information.
0.05%
Subsidiaries
에이프로젠제약㈜
Company Performance
Financial values in the chart are available after Schnell Bio Pharmaceuticals Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.68%▲
Total Operating Revenue
-34.23%▼
Operating Profit
-75.33%▼
EBITDA
-47.66%▼
Net Profit/Loss for the Period
-60.31%▼
Total Assets
-0.68%▼
Total Equity
-26.7%▼
Operating Profit Margin
-102.5%▼
Net Profit Margin
-74.02%▼
Return on Equity (ROE)
-32.91%▼
Debt / Equity
40.51%▲
Quick Ratio
0.02%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo